论文部分内容阅读
在诸多失败之后,年轻的生物技术公司们能够成功地捕捉到难以捉摸的药物靶标吗?他们认为可以。一个之前不可成药的靶标:神经元型一氧化氮合酶(上方)结合一个抑制物(红色标出)以及Mcl-1(下方)被一个固定化多肽修饰(蓝色带有一个红色钩环)
After many failures, can young biotech companies successfully capture the elusive drug targets? They think they can. One previous non-drug target: neuronal nitric oxide synthase (top) binds an inhibitor (red) and Mcl-1 (bottom) is modified with an immobilized polypeptide (blue with a red collar)